Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
An early clinical trial at U-M finds that a Wee1 inhibitor, combined with radiation and gemcitabine, is safe and potentially effective in pancreatic cancer treatment.
A survey of early career oncologists suggests onsite child care could open scientific meetings to more women attendees.
Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.
When the surgical wound doesn’t heal right, it can send some patients back to the operating room.
A U-M study is the first to define how a little-known type of cell death impacts tumor cells and immune cells.
Clinical trial shows promise of immune treatment against HPV infections that lead to cancer
